Identification and characterization of missense alterations in the BRCA1 associated RING domain (BARD1) gene in breast and ovarian cancer

Journal of Medical Genetics

Volumn 42, Issue 8, 2005, Pages 633-638

  Sauer, M K ^a   Andrulis, I L ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 ASSOCIATED RING DOMAIN PROTEIN 1; BRCA1 PROTEIN; PROTEIN P53;

ALLELE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER GENETICS; CANCER INHIBITION; CONTROLLED STUDY; DNA CONFORMATION; DNA POLYMORPHISM; FEMALE; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; HEMIZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN CELL; HUMAN TISSUE; MISSENSE MUTATION; ONCOGENE; OVARY CANCER; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; UTERUS CANCER;

BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; MUTATION, MISSENSE; OVARIAN NEOPLASMS; PROTEIN STRUCTURE, TERTIARY; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES;

EID: 23744479222     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.2004.030049     Document Type: Article

References (35)

1. Sauer MK. Recent advances in the identification of genetic and biochemical components of breast cancer predisposition. Curr Genomics 2002;3:389-412.
2. Wu LC, Wang ZW, Tsan JT, Spillman MA, Phung A, Xu XL, Yang MC, Hwang LY, Bowcock AM, Baer R. Identification or a RING protein that can interact in vivo with the BRCA1 gene product. Nat Genet 1996;14:430-40.
3. Ghimenti C, Sensi E, Presciuttini S, Brunetti IM, Conte P-F, Bevilacqua G, Caligo MA. Germline mutations of the BRCA1-associated ring domain (BARD1) gene in breast and breast/ovarian families negative for BRCA1 and BRCA2 alterations. Genes Chromosomes Cancer 2002;33:235-42.
4. Ishitobi M, Miyoshi Y, Hasegawa S, Egawa C, Tamaki Y, Monden M, Noguchi S. Mutational analysis of BARD1 in familial breast cancer patients in Japan. Cancer Lett 2003;200:1-7.
5. Karppinen SM, Heikkinen K, Rapakko K, Winqvist R. Mutation screening of the BARD1 gene: evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancer. J Med Genet 2004;41:e114.
6. Thai TH, Du F, Tsan JT, Jin Y, Phung A, Spillman MA, Massa HF, Muller CY, Ashfaq R, Mathis JM, Miller DS, Trask BJ, Baer R, Bowcock AM. Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers. Hum Mol Genet 1998;7:195-202.
7. Rodriguez JA, Schuchner S, Au WW, Fabbro M, Henderson BR. Nuclear-cytoplasmic shuttling of BARD1 contributes to its proapoptotic activity and is regulated by dimerization with BRCA1. Oncogene 2004;23:1809-20.
8. Irminger-Finger I, Leung W-C. BRCA1-dependent and independent functions of BARD1. Int J Biochem Cell Biol 2002;34:582-7.
9. Baer R, Ludwig T. The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity. Curr Opin Genet Dev 2002;12:86-91.
10. Fabbro M, Savage KI, Hobson K, Deans AJ, Powell SN, McArthur GA, Khanna KK. BRCA1/BARD1 complexes are required for p53Ser15 phosphorylation and a G1/S arrest following IR-induced DNA damage. J Biol Chem 2004;279:31251-8.
11. Meza JE, Brzovic PS, King MC, Klevit RE. Mapping the functional domains of BRCA1. Interaction of the ring finger domains of BRCA1 and BARD1. J Biol Chem 1999;274:5659-65.
12. Brzovic PS, Rajagopal P, Hoyt DW, King MC, Klevit RE. Structure of a BRCA1-BARD1 heterodimeric RING-RING complex. Nat Struct Biol 2001;8:833-7.
13. Morris JR, Keep NH, Solomon E. Identification of residues required for the interaction of BARD1 with BRCA1. J Biol Chem 2002;277:9382-6.
14. Brzovic PS, Meza JE, King MC, Klevit RE. BRCA1 RING domain cancer-disposing mutations. J Biol Chem 2001;244:42399-406.
15. Irminger-Finger I, Soriano JV, Vaudan G, Montesano R, Sappino AP. In vitro repression of Brca1-associated RING domain gene, Bard1, induces phenotypic changes in mammary epithelial cells. J Cell Biol 1998;143:1329-39.
16. Soriano JV, Irminger-Finger I, Uyttendaele H, Vaudan G, Kitajewski J, Sappino AP, Montesano R. Repression of the putative tumor suppressor gene Bard1 or expression of Notch4(int-3) oncogene subvert the morphogenetic properties of mammary epithelial cells. Adv Exp Med Biol 2000;480:175-84.
17. Irminger-Finger I, Leung W-C, Li J, Dubois-Dauphin M, Harb J, Feki A, Jefford CE, Soriano JV, Jaconi M, Montesano R, Krause K-H. Identificaion of BARD1 as mediator between proapoptotic stress and p53-dependent apoptosis. Mol Cell 2001;8:1255-66.
18. Jefford CE, Feki A, Harb J, Krause KH, Irminger-Finger I. Nuclear-cytoplasmic translocation of BARD1 is linked to its apoptotic activity. Oncogene 2004;23:3509-20.
19. Ruffner H, Joazeiro CA, Hemmati D, Hunter T, Verma IM. Cancer-predisposing mutations within the RING domain of BRCA1: Loss of ubiquitin protein ligase activity and protection from radiation hypersensitivity. Proc Natl Acad Sci USA 2001;98:5134-9.
20. Hashizume R, Fukuda M, Maeda I, Nishikawa H, Oyake D, Yabuki Y, Ogata H, Ohta T. The ring heterodimer brca1-bard1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation. J Biol Chem 2001;276:14537-40.
21. Chen A, Kleiman FE, Manley JL, Ouchi T, Pan Z-Q. Autoubiquitination of the BRCA1-BARD1 RING ubiquitin ligase. J Biol Chem 2002;277:22085-92.
22. Morris JR, Solomon E. BRCA1:BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair. Hum Mol Genet 2004;13:807-17.
23. Xia Y, Pao GM, Chen HW, Verma IM, Hunter T. Enhancement of BRCA1 E3 ubiquitin ligase activity through direct interaction with the BARD1 protein. J Biol Chem 2003;278:5255-63.
24. Kentsis A, Gordon RE, Borden KL. Control of biochemical reactions through supramolecular RING domain self-assembly. Proc Natl Acad Sci USA 2002;99:15404-9.
25. Dong Y, Hakimi MA, Chen X, Kumaraswamy E, Cooch NS, Godwin AK, Shiekhattar R. Regulation of BRCC, a holoenzyme complex containing BRCA1 and BRCA2, by a signalosome-like subunit and its role in DNA repair. Mol Cell 2003;12:1087-99.
26. Brzovic PS, Keeffe JR, Nishikawa H, Miyamoto K, Fox D, III, Fukuda M, Ohta T, Klevit R. Binding and recognition in the assembly of an active BRCA1/BARD1 ubiquitin-ligase complex. Proc Natl Acad Sci USA 2003;100:5646-51.
27. Kleiman FE, Manley JL. Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50. Science 1999;285:1576-9.
28. Kleiman FE, Manley JL. The BARD1-CstF-50 interaction links mRNA 3′ end formation to DNA damage and tumor suppression. Cell 2001;104:743-53.
29. Spahn L, Petemann R, Siligan C, Schmid JA, Aryee DNT, Kovar H. Interaction or the EWS NH2 terminus with BARD1 links the Ewing's sarcoma gene to a common tumor suppressor pathway. Cancer Res 2002;62:4583-7.
30. Dechend R, Hiran F, Lehmann K, Heissmeyer V, Ansieau S, Wulczvn FG, Scheidereit C, Leutz A. The Bcl-3 oncoprotein acats as a bridging factor between NF-kB/Rel and nuclear co-regulators. Oncogene 1999;18:3316-23.
31. Andrulis IL, Bull SB, Blackstein ME, Sutherland D, Mak C, Sidlofsky S, Pritzker KP, Hartwick RW, Hanna W, Lickley L, Wilkinson R, Qizifcash A, Ambus U, Lipa M, Weizel H, Katz A, Baida M, Mariz S, Stoik G, Dacamara P, Strongitharm D, Geddie W, McCready D. neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. J Clin Oncol 1998;16:1340-9.
32. Laframboise S, Chapman W, McLaughlin J, Andrulis IL. p53 mutations in epithelial ovarian cancers: possible role in predicting chemoresistance. Cancer J 2000;6:302-8.
33. Cormak B. Mutagenesis of cloned DNA. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, eds. Current protocols in molecular biology. Boston: Greene, Wiley Interscience, 2004:8.5.1-.9.
34. Jin Y, Xu XL, Yang MC, Wei F, Ayi TC, Bowcock AM, Baer R. Cell cycle-dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains. Proc Natl Acad Sci USA 1997;94:12075-80.
35. Mallery DL, Vandenberg CJ, Hiom K. Activation of the E3 ligase function of the BRCA1/BARD1 complex by polyubiquitin chains. EMBO J 2002;21:6755-62.